chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient waiting 15 minutes to see if no reactions with vaccines, after 5 minutes after administering vaccines, patient fainted in room, ambulance was called per Provider and patient was taken via ambulance to Hospital. Patient followed up in office today 07/19/2023  with our provider.
Fever (not well documented) X 1 week after shot @ 2 months, Very fussy 1st 3-4 hours after shot, Had generalized tonic Clonic seizure 3-4 hours after shots, lasting 2-3 minutes, "Dazed"  X 24 hours after seizure
On 4:00 PM theday of immunizations the patient had a fever of 102. The next day he vomited 1 time. He had diarrhea Friday or Saturday, for 4 days, irritable. The patient wakes up screaming 20 times in one night. Fever for 3-4 days.
Slight rash 50 mm x 50mm. Advised to give liquid Advil +/or Benadryl and apply cold pack. Given recheck appointment for Monday 12/20/2004. Advised to call doctor over weekend if area gets worse.
Swelling in axilla.  Patient applied ice and swelling went down.  No further reaction.
Diagnosed with Chronic ITP a blood disorder 2 months after receiving shots. Has had severely low platelets. Has had multiple Blood infusions, been on steroids, bone marrow stimulators, had bone marrow testing and most recently 10/25/17 had spleen removed and put on Penicillin twice a week for the rest of his life. All due to the Chronic ITP. It is about 2 1/2 years now, and will have to deal with it for the rest of his life.
Pt complained of rash, itching, and swelling that lasted up to 1 week. Pt confirmed she did not use anything to treat.
This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got COVID-19 virus) and DRUG INEFFECTIVE (received first Moderna booster in Aug-2021 and had Covid-19 in Jan-2022) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In August 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In January 2022, the patient experienced COVID-19 (got COVID-19 virus) and DRUG INEFFECTIVE (received first Moderna booster in Aug-2021 and had Covid-19 in Jan-2022). At the time of the report, COVID-19 (got COVID-19 virus) and DRUG INEFFECTIVE (received first Moderna booster in Aug-2021 and had Covid-19 in Jan-2022) outcome was unknown. No concomitant medication was reported. No treatment information was provided. Company comment: This spontaneous case concerns a male patient of unknown age with no reported medical history, who experienced the unexpected, non-serious adverse event of special interest COVID-19. Additionally, Drug ineffective was also reported. The exact date of onset of the event and administration of third dose of mRNA-1273 was not provided, hence latency could not be assessed. The initial two doses of mRNA-1273 were administered on unspecified dates. Details of concomitant medications, medical history, clinical course, treatment and outcome were not provided. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Reporter did not allow further contact. Sender's Comments: This spontaneous case concerns a male patient of unknown age with no reported medical history, who experienced the unexpected, non-serious adverse event of special interest COVID-19. Additionally, Drug ineffective was also reported. The exact date of onset of the event and administration of third dose of mRNA-1273 was not provided, hence latency could not be assessed. The initial two doses of mRNA-1273 were administered on unspecified dates. Details of concomitant medications, medical history, clinical course, treatment and outcome were not provided. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
HEAVY VAGINAL BLEEDING OVER A YEAR. NOT JUST HEAVY MENSTRUAL BLEEDING, HEAVY VAGINAL BLEEDING. OFF AND ON, BUT MORE OFTEN ON.; This spontaneous report received from a health care professional concerned a 4 decade old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 07-SEP-2021 for covid-19 prophylaxis. No concomitant medications were reported. On 2021, the patient experienced heavy vaginal bleeding over a year, not just heavy menstrual bleeding, heavy vaginal bleeding off and on, but more often on. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from heavy vaginal bleeding over a year, not just heavy menstrual bleeding, heavy vaginal bleeding off and on, but more often on. This report was non-serious.; Sender's Comments: V0-Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
Two hours after the vaccine my left jaw locks up  Throbbing tooth pain  face droopy
I tested positive on the 2nd even though I was symptomatic on the 1st. Body ache, fever, congestion. I took PAXLOVID from the 2nd. I tested negative on the 21st. I had severe symptoms in the beginning and around the 11/12. I was sleeping less than 16 hours a day, was less fatigues. On the 14th I had  a ear and sinus infection and was put on medication. I was still extremely tired up to a week ago. Now today I don't have the fog and not sleeping up to 16 hours a day anymore. On the 21st I tested negative.
This case involves Adult male patient who experienced vaccination to which he had a reaction (vaccination site reaction), after receiving vaccine YELLOW FEVER VACCINE. The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. No other concomitant vaccines were not provided. On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE produced by unknown manufacturer (lot number and expiry date was not reported) via an unknown route at an unknown administration site for prophylactic vaccination. On an unknown date, the patient developed a non-serious vaccination to which he had a reaction (vaccination site reaction) (unknown latency) following the administration of YELLOW FEVER VACCINE. It was unknown if the patient experienced any additional symptoms/events. Details of laboratory data and results were not reported. It was not reported if the patient received any corrective treatment for the event. At time of reporting, outcome of the event was unknown. There will be no information available on batch number for this case.
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 03-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported.
arm was a little sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021252141 (same vaccine, different dose, similar event).  A 66 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 27Feb2021 09:50 (Lot number: EN6201) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes 1" (ongoing); "Diabetes 2" (ongoing); "muscle spasticity" (ongoing); "High blood pressure" (ongoing). Concomitant medication(s) included: INSULIN taken for diabetes mellitus; METFORMIN taken for diabetes mellitus; BACLOFEN taken for muscle spasticity; LISINOPRIL taken for hypertension; METOPROLOL taken for hypertension; CALCIUM PLUS VITAMIN D (ongoing); TYLENOL; PANTOPRAZOLE taken for gastrooesophageal reflux disease, gastrooesophageal reflux disease (ongoing); FUROSEMIDE (ongoing); ELIQUIS taken for anticoagulant therapy (ongoing).  The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "arm was a little sore". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity.  Additional information: No prior vaccination within 4 weeks. Concomitant therapy included Multivitamins also.  No follow-up attempts are possible. No further information is expected.
My COVID-19 symptoms started on 04/01/2023 in the afternoon. I had a  fever, body aches and slight cough . I felt like it was a cold.  When I saw my temperature was over 103.00.  I went to the urgent care right away and they tested me for COVID-19 infection. They prescribe me with Paxlovid for 5 days. They advised me not to take my cholesterol medications and wait 5 days after.
This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown), via an unspecified route of administration in Jan2021 (on Thursday) at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Caller received the first dose of the vaccine on Thursday in Jan2021 and she's felling bad, she couldn't go to work and would like to know what she could do. Had been down ever since. Couldn't get out of bed. Has a temperature. Felt so bad she couldn't go into work today (18Jan2021). Not sure what's going on. Clarified she's referring to the Pfizer COVID-19 Vaccine. Had she known what she knows now she would not have taken it. The patient was hot, sweating, and dizzy. (Facility name) administered the COVID-19 Vaccine. Didn't know if she needs to go get tested. Felt like crap. Felt bad. Hasn't been out of bed in three days. Requested to be transferred. The outcome of the events was unknown. Information on the Batch/Lot number has been requested.
Rt deltoid area became swollen (up to golf ball size), warm to touch, very tender and sensitive nodule, Ibuprofen 200 mg 2 tab periodically for 3-4 days.
Swelling, redness, itching, and tissue rigidity in right arm where vaccinated on day one. Day two and three, swelling, itching & rigidity persisted with redness spreading down arm past elbow. On day four and five, child shows flushing of cheeks, as well as continued redness and itching of arm.
Vaccine adverse reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Vaccine adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccine adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccine adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. No treatment was reported.
felt crappy; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt crappy), CHILLS (chills) and PYREXIA (fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included TOFACITINIB CITRATE (XELJANZ) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (felt crappy), CHILLS (chills) and PYREXIA (fever). At the time of the report, FEELING ABNORMAL (felt crappy), CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information not provided   Reporter did not allow further contact
Pt. ran fever 6 hours after vaccines of over 105 degrees & was seizing.  Parents took child to E.R. where fever & seizures were controlled & child was released.
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2 (BNT162B2), on 05Apr2022 as dose 1, single (Batch/Lot number: unknown), in left arm and on 27Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 42 years, in right arm for COVID-19 immunization; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 15Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for COVID-19 immunization. The patient's relevant medical history included: "History of allergic rhinitis" (unspecified if ongoing); "eosinophilic esophagitis" (unspecified if ongoing); "chronic gastritis" (unspecified if ongoing). Concomitant medication(s) included: FEXOFENADINE; VYVANSE; NASACORT; PANTOPRAZOLE; AZITHROMYCIN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (21May2022) Positive, notes: I completed a rapid antigen test and was positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: On 21May22, patient felt that COVID-19 symptoms was returning. Fever and fatigue specifically. Patient completed a rapid antigen test and was positive. Anti-Viral Details: (Product: COVID 19 Treatment). Treatment Start Date=13May2022, treatment Stop Date=18May2022.  No follow-up attempts are possible. No further information is expected.
Pt. woke up 2 days ago, a day after receiving hepatitis a, with swollen red patches on her arms, legs. By she arrived at the ER 8/21/12 her hands, legs and knees were swollen, ears were swollen as well. She went to ER and was given diphenhydramine and oral steroid. The rash went away, but the next day they appeared as little dots on the face that later became a confluent hive. She went back, to ER, 8/22/12 and was given a prescription for oral steroids for 3 days, today is first day of that. Didn't clear up until today 8/23. No respiratory symptoms. No fever. No lip swelling, no vomiting.
This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported. On an unspecified date, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) rHA (Lot# U002535and expiration date 24-JUL-2022) (exact dose and frequency were not reported) as prophylaxis. (product storage error). The vaccine underwent a temperature excursion of 6.4 Fahrenheit for 2 hours 30 minutes and 0 seconds. There was no previous temperature excursion. No further information provided.
Pt was a nonseroconverter p/ a series of 3 doses of Engerix-B; 2 Booster doses will be administered;
Patient developed subsequent substernal chest pain. He does have history of Myocardiatis/Pericarditis, for this reason when I saw him on 10/25/2021 I referred him to the ER for evaluation of chest pain. He was diagnosed with Pulmonary Embolism.
Left hand got red and itchy; Left hand got red and itchy; This is a spontaneous report from a contactable healthcare professional (patient). An 84-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine; lot number: EL3247), via an unspecified route of administration in the left arm on 20Jan2021 10:00 at a single dose for covid-19 immunization. Medical history included allergies Penicillin and allergies: sulphur IV dye. Concomitant medication included omeprazole (PRILOSEC), levothyroxine sodium (SYNTHROID) and amlodipine besylate. The patient previously took augmentin [amoxicillin;clavulanic acid] and Sulphur where patient experienced allergies. On 20Jan2021 21:30, the patient experienced left hand got red and itchy. The patient was not diagnosed with covid-19 prior vaccination and has not been tested for covid-19 since the vaccination. The patient did not receive treatment for the event. The outcome of the events was not recovered.
both eyes were swollen; no fever; legs fine w/o reddness or swelling; pt rx w/Atarax followed by office visit on Monday;
redness in left arm; swelling of muscle, itchy,miniscule pain except when raising upper arm..
Pt felt "strange and uneasy"  right after the vaccine.  Sunday (3 days post shot) pt had very dry mouth, numb  tongue, and sore inside his mouth.  Patient's wife reports slurred speech.  Symptoms have been slowly getting worse since Sunday.
pt recvd vax & 2 days later exp caudate infarction;pt hospitalized for 6 days;had been discharged from the hosp;
This spontaneous report was received from a certified medical assistant and refers to a 9 year old male patient. Information on the patient's concurrent conditions, medical history or concomitant medications was not reported. On 27-APR-2016 at 17:06, the patient was vaccinated with GARDASIL 9 (lot # M004116, expiration date: 12-OCT-2017) dose 1, intramuscularly in the right arm. On unspecified date, the vaccine that was administered to the patient had been improperly stored by being exposed to temperature: 34 F for a total time of 65 hours. There were no previous temperature excursions. No adverse event, signs or symptoms were reported. The patient had no illnesses at time of vaccination. This is one of several reports received from the same source. Additional information is not expected as all available information was obtained.
This retrospective pregnancy case was reported in a literature article and described the occurrence of premature birth in a 18-year-old female subject who was vaccinated with DTPa (with small D & P), manufacturer unspecified). On an unspecified date, the subject received unspecified dose of DTPa (with small D & P) (unknown route and injection site). Her last menstrual period was on an unspecified date and estimated date of delivery was not provided. The subject was exposed to the vaccine during unspecified trimester. On an unspecified date, after 35 weeks of gestation, the subject gave birth to a premature live infant by unspecified method of delivery. No congenital anomaly was reported. The subject was hospitalised.
very tired; foggy headed; slight sore injection site; feel very lethargic; hard to focus at work; just want to sleep; This is a spontaneous report from a contactable nurse (patient). An adult patient of an unspecified gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL1284), intramuscular in the left arm on 29Dec2020 17:45 at a single dose for COVID-19 immunization. The patient's medical history included allergies to bee stings. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took intravenous (IV) magnesium and experienced head to toe rash. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 30Dec2020 07:00, the patient was very tired, a bit foggy headed, slight sore injection site, overall just feel very lethargic/tired. The patient just want to sleep. It was a bit hard to focus at work. No treatment was received for the adverse events. Outcome of the events was unknown. The events were considered non-serious.
Patient was administered with vaccine that was beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine that was beyond use date after the thaw process) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient had acute illness at the time of vaccination and up to one month before.     On 28-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine that was beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine that was beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the age of patient was 84 years 10 months. No concomitant medications were reported It was unknown if patient had been diagnosed with or tested positive for COVID-19, nor if patient had chronic or long lasting health conditions. Patient received third dose of vaccine and had reported no adverse reactions after the administration. No treatment medication were reported. On 10-Jun-2022, the vaccination facility was made aware of administration of vaccines beyond use date after the thaw process while audit was conducted. Patient got Moderna with vaccine Ndc code.
Whole body chills and aches, sore armpits, soreness at the site of injection. Aches and chills last throughout the night, but then subsided after taking a dose of Tylenol at 6:30am.
Middle of Jul2021 , rash and went to doctor in Jul2021.Shingles diagnosed
Moderna COVID-19 Vaccine EUA. Sore arm, immediately following injection and throughout. Mild headache, began 5pm on 4/17/2021. Chills & fever, began 7pm.  Chills & fever increased, 8pm. Highest fever, midnight on 4/18/2021. Fever lessened, fatigue, headache, began 01:00.  Migraine headache, mild fever, began 03:00. Migraine continues, mild fever, nausea, vomiting, began 15:00. All symptoms gone, 18:00pm.
The night after receiving my vaccine, I had a fever of 101, I had chills, no appetite and a really bad headache. I called my doctor on 10/04 and scheduled an appointment. When I went in for my appointment, I did not have my fever anymore, but I still had all other symptoms. My doctor gave me off work and told me to take Emergen-C. As of today, everything is back to normal.
My glands swelled up. I am a sore. In September I had a running nose, headache, and body ache. I got a Covid-19 test, was negative. My nose is still running. I wake up this morning my throat hurt and my ears hurt a little.
Pt described a popping sound and pain at site after vaccine administration- limited mobility followed shortly after. Pain/ mobility had not improved after a few weeks so pt scheduled visit with his PCP where he was diagnosed with bursa. Pt was given NSAID therapy and a variety of light muscle workouts to be started this month.
swelling, redness, firmness, itching, discomfort over last 2 days, redness has increased in size to area that is 11 cm x 13 cm.
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Patient presenting 8 days post vaccination with decreased ROM in injection site shoulder/arm with tingling down extremity.